HCW Biologics Inc. (HCWB)

HCW Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.67	3.6	22.33	11.73	8.46
Short-Term Investments	-	-	9.74	24.98	-
Cash & Short-Term Investments	4.67	3.6	32.06	36.71	8.46
Cash Growth	30.03%	-88.79%	-12.67%	334.19%	14.95%
Accounts Receivable	0.58	1.54	0.42	-	2.5
Other Receivables	-	-	-	0.13	-
Receivables	0.58	1.54	0.42	0.13	2.5
Prepaid Expenses	0.33	1.04	1.39	2.2	0.54
Other Current Assets	0.11	0.23	0.2	1.44	0.65
Total Current Assets	5.7	6.4	34.07	40.48	12.15
Property, Plant & Equipment	22.91	20.48	10.8	1.12	1.62
Long-Term Investments	1.6	1.6	1.6	11.52	1.6
Other Long-Term Assets	0.03	0.03	0.33	0.39	0.03
Total Assets	30.24	28.51	46.81	53.51	15.4
Accounts Payable	22.33	6.17	1.23	0.22	0.16
Accrued Expenses	0.98	2.43	1.55	0.3	0.28
Short-Term Debt	6.31	-	-	-	0.57
Current Portion of Long-Term Debt	-	0.12	-	-	-
Current Portion of Leases	-	0.03	0.18	-	-
Current Unearned Revenue	-	-	-	1.8	-
Total Current Liabilities	29.63	8.75	2.96	2.32	1
Long-Term Debt	7.38	6.3	6.41	-	-
Long-Term Leases	-	-	0.01	-	-
Total Liabilities	37.01	15.05	9.38	2.32	1
Common Stock	0	0	0	0	0
Additional Paid-In Capital	93.78	83.99	82.96	81.83	-
Retained Earnings	-100.56	-70.53	-45.54	-30.64	-16.72
Total Common Equity	-6.77	13.46	37.43	51.19	-16.72
Shareholders' Equity	-6.77	13.46	37.43	51.19	14.4
Total Liabilities & Equity	30.24	28.51	46.81	53.51	15.4
Total Debt	13.69	6.45	6.6	-	0.57
Net Cash (Debt)	-9.02	-2.86	25.46	36.71	7.89
Net Cash Growth	-	-	-30.65%	365.41%	7.24%
Net Cash Per Share	-0.23	-0.08	0.71	1.96	1.66
Filing Date Shares Outstanding	44.93	37.82	35.89	35.78	4.79
Total Common Shares Outstanding	44.54	36.03	35.88	35.77	4.79
Working Capital	-23.93	-2.34	31.11	38.16	11.15
Book Value Per Share	-0.15	0.37	1.04	1.43	-3.49
Tangible Book Value	-6.77	13.46	37.43	51.19	-16.72
Tangible Book Value Per Share	-0.15	0.37	1.04	1.43	-3.49
Land	-	2.15	2.15	-	-
Buildings	-	6.11	6.11	-	-
Machinery	-	2.66	2.62	2.42	2.37
Construction In Progress	-	10.44	0.05	-	-
Leasehold Improvements	-	0.35	0.35	0.35	0.35

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q